MAPK3 and Miyoshi myopathy: Our studies of MM patient samples indicate that MM cells co-cultured with or without autologous BMSC-CM remain equally sensitive to Erk1/2i + CDK4/6i, suggesting that this drug combination can overcome the protective effects of the MM-BM-milieu.